ALFFX | VSGAX | ALFFX / VSGAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 13 years | - |
Gain YTD | -2.241 | -0.325 | 689% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 593M | 39.6B | 1% |
Annual Yield % from dividends | 0.15 | 0.66 | 23% |
Returns for 1 year | 7.11 | 12.95 | 55% |
Returns for 3 years | 2.00 | 19.38 | 10% |
Returns for 5 years | 14.90 | 35.62 | 42% |
Returns for 10 years | -13.13 | 116.34 | -11% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWVX | 72.83 | 1.47 | +2.06% |
Rydex Emerging Markets 2X Strategy H | |||
JFNSX | 67.87 | -0.48 | -0.70% |
Janus Henderson Global Life Sciences S | |||
VAGVX | 27.26 | -0.25 | -0.91% |
Vanguard Advice Select Global Value Adml | |||
NQGAX | 36.33 | -0.37 | -1.01% |
Nuveen Global Equity Income A | |||
GSLIX | 16.61 | -0.25 | -1.48% |
Goldman Sachs Large Cap Value Instl |